With box warnings

Without box warnings

Branded

Generic

5 results

datroway
(Datopotamab Deruxtecan)
Daiichi Sankyo Inc.
Usage: DATROWAY is indicated for adult patients with unresectable or metastatic, hormone receptor-positive, HER2-negative breast cancer who have previously received endocrine-based therapy and chemotherapy.
enhertu
(fam-trastuzumab deruxtecan-nxki)
Daiichi Sankyo Inc.
Usage: ENHERTU is indicated for treating adult patients with unresectable or metastatic HER2-positive breast cancer, HER2-low or HER2-ultralow breast cancer, HER2-mutant non-small cell lung cancer, advanced HER2-positive gastric cancer, and unresectable HER2-positive solid tumors, all following prior systemic therapies.
savaysa
(EDOXABAN TOSYLATE)
Daiichi Sankyo Inc.
Usage: SAVAYSA is indicated for reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation and for treating deep vein thrombosis and pulmonary embolism after initial therapy with a parenteral anticoagulant. It should not be used in patients with CrCL > 95 mL/min.
vanflyta
(QUIZARTINIB)
Daiichi Sankyo Inc.
Usage: VANFLYTA is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) that is FLT3 ITD-positive. It is used in combination with chemotherapy for induction and consolidation, and as maintenance monotherapy post-consolidation. Not for use after allogeneic stem cell transplantation.
welchol - colesevelam hydrochloride tablet, film coated
(Colesevelam Hydrochloride)
Daiichi Sankyo Inc.

Daiichi Sankyo Inc. drugs

datroway